KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Tax Rate (2019 - 2024)

Historic Tax Rate for Alnylam Pharmaceuticals (ALNY) over the last 10 years, with Q3 2025 value amounting to 5.07%.

  • Alnylam Pharmaceuticals' Tax Rate fell 23900.0% to 5.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 236.38%, marking a year-over-year increase of 2398600.0%. This contributed to the annual value of 26.29% for FY2024, which is 278400.0% up from last year.
  • Alnylam Pharmaceuticals' Tax Rate amounted to 5.07% in Q3 2025, which was down 23900.0% from 87.45% recorded in Q2 2025.
  • Alnylam Pharmaceuticals' Tax Rate's 5-year high stood at 56.81% during Q4 2024, with a 5-year trough of 87.45% in Q2 2025.
  • In the last 5 years, Alnylam Pharmaceuticals' Tax Rate had a median value of 0.65% in 2021 and averaged 7.03%.
  • Over the last 5 years, Alnylam Pharmaceuticals' Tax Rate had its largest YoY gain of 569500bps in 2024, and its largest YoY loss of -505800bps in 2024.
  • Over the past 5 years, Alnylam Pharmaceuticals' Tax Rate (Quarter) stood at 0.71% in 2021, then plummeted by -132bps to 0.23% in 2022, then skyrocketed by 42bps to 0.13% in 2023, then skyrocketed by 42846bps to 56.81% in 2024, then plummeted by -109bps to 5.07% in 2025.
  • Its Tax Rate stands at 5.07% for Q3 2025, versus 87.45% for Q2 2025 and 38.18% for Q1 2025.